Novavax announces it will focus vaccine development on Omicron BA.4/5 subvariants This link will open in a new window, expecting to be able to provide an Omicron targeted-vaccine in late 2022.
AstraZeneca collaborates with Amref Health Africa and the Kenyan Ministry of Health to support the set-up of mobile clinics This link will open in a new window providing COVID-19 screening, vaccinations and post-immunization care in “last mile” communities.
Pfizer and BioNTech announce submission to the EMA of its Omicron-adapted bivalent COVID-19 vaccine candidate This link will open in a new window for individuals 12 years of age and older.